Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 875 across all filing types
Latest filing 2018-02-08 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Another patent approval in the US related to Episurf Medical’s 3D-based damage assessment tool
Regulatory Filings Classification · 95% confidence The document announces the approval of a new patent by the United States Patent and Trademark Office (USPTO) for Episurf Medical. It discusses intellectual property protection and includes contact information and a boilerplate 'About' section. This type of announcement, concerning specific legal or intellectual property developments that are not standard financial reports (10-K, IR, ER), fits best under the general category for regulatory or specific corporate announcements that don't have a dedicated code. Since it is not a Director's Dealing (DIRS), a Legal Proceeding Report (LTR, which usually implies litigation), or a financing update (CAP), the most appropriate fallback category is Regulatory Filings (RNS), as it is a formal announcement of a significant corporate event related to IP.
2018-02-08 English
Förändring av antalet aktier och röster i Episurf Medical
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text, written in Swedish, announces a change in the number of shares and votes due to the conversion of A-shares to B-shares ('Förändring av antalet aktier och röster'). It explicitly states the new total number of shares (30,549,495) and the breakdown of A and B shares. This directly relates to changes in the company's capital structure or share issuance. Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for reporting changes in the total number of shares outstanding, even if resulting from internal conversion rules.
2018-01-31 Swedish
Change in number of shares and votes in Episurf Medical
Share Issue/Capital Change Classification · 99% confidence The document explicitly details a 'Change in number of shares and votes' due to 'conversions of class A shares to B shares'. It specifies the resulting total number of A shares, B shares, and total votes. This directly relates to a change in the company's capital structure or share issuance details. The most appropriate category is 'Share Issue/Capital Change' (SHA), as it documents a structural change in the share classes and total count. It is not a dividend notice (DIV), a director's dealing (DIRS), or a general earnings release (ER). Given the specific nature of the share class change, SHA is a better fit than the general 'Regulatory Filings' (RNS). The document length is short, but it contains the substantive information, not just an announcement of an attachment.
2018-01-31 English
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for an issuer (Episurf Medical AB) by a holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension). It explicitly mentions 'Reason for major shareholding notification Buy' and provides detailed tables showing the 'Before the transaction' and 'After the transaction' quantities and percentages of shares and voting rights. This structure is characteristic of a notification regarding a significant change in ownership, which aligns with the definition of Major Shareholding Notification (MRQ). The document is short and appears to be the notification itself, not an announcement of a report.
2018-01-23 English
Episurf Medical erhåller marknadsgodkännande i Israel och ingår distributörsavtal för den israeliska marknaden
Regulatory Filings Classification · 90% confidence The document announces two key events: receiving market approval in Israel for the Episealer® knee implant and entering into a distributor agreement with AMI Technologies Ltd. for the Israeli market. It includes a quote from the CEO and concludes with a statement that the information is required to be made public under the EU Market Abuse Regulation (MAR) and was released on January 18, 2018. This type of announcement, which details specific operational news (market entry, regulatory clearance, distribution deals) but is not a full financial report (10-K, IR) or a standard earnings release (ER), fits best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). It is too specific for RNS, but since it is not a standard financial report, management change, or capital event, RNS serves as the most appropriate catch-all for significant, non-standard operational news releases.
2018-01-18 Swedish
Episurf Medical receives market approval in Israel and signs distribution agreement for the Israeli market
Regulatory Filings Classification · 95% confidence The document announces two key events: market approval in Israel from the Israeli Ministry of Health and the signing of a distribution agreement with AMI Technologies Ltd. This type of announcement, detailing business development, regulatory milestones, or strategic agreements, does not fit the specific financial reporting codes (10-K, IR, ER, AR) or corporate governance codes (DEF 14A, DVA). It is a general corporate update. Since it is not a report announcement (RPA) but the news itself, and it doesn't fit M&A (TAR), Capital (CAP), or Director Dealing (DIRS), the most appropriate general category for significant, non-standard corporate news that doesn't fit elsewhere is the Regulatory Filings fallback category (RNS), as this often covers press releases detailing operational or regulatory achievements.
2018-01-18 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.